Mehdi Rajabi

2.4k total citations · 1 hit paper
54 papers, 1.9k citations indexed

About

Mehdi Rajabi is a scholar working on Molecular Biology, Organic Chemistry and Toxicology. According to data from OpenAlex, Mehdi Rajabi has authored 54 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 16 papers in Organic Chemistry and 9 papers in Toxicology. Recurrent topics in Mehdi Rajabi's work include Synthesis and biological activity (10 papers), Bioactive Compounds and Antitumor Agents (9 papers) and Synthesis of Organic Compounds (5 papers). Mehdi Rajabi is often cited by papers focused on Synthesis and biological activity (10 papers), Bioactive Compounds and Antitumor Agents (9 papers) and Synthesis of Organic Compounds (5 papers). Mehdi Rajabi collaborates with scholars based in United States, Iran and Italy. Mehdi Rajabi's co-authors include Shaker A. Mousa, Mathangi Srinivasan, Mohammad A. Khalilzadeh, Dan Shu, Peixuan Guo, Yi Shu, Mohamed Nadjib Boukhatem, Enzo Santaniello, Zinatossadat Hossaini and Fengmei Pi and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and Cancer Research.

In The Last Decade

Mehdi Rajabi

52 papers receiving 1.9k citations

Hit Papers

The Role of Angiogenesis ... 2017 2026 2020 2023 2017 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mehdi Rajabi United States 21 960 420 263 235 214 54 1.9k
Vilma Petrikaitė Lithuania 25 707 0.7× 355 0.8× 310 1.2× 174 0.7× 354 1.7× 89 1.8k
Fatemeh Mosaffa Iran 26 1.0k 1.1× 351 0.8× 443 1.7× 174 0.7× 242 1.1× 86 1.9k
Konstantinos Dimas Greece 26 1.1k 1.2× 330 0.8× 453 1.7× 169 0.7× 148 0.7× 85 2.1k
Milica Pešić Serbia 29 1.3k 1.3× 308 0.7× 476 1.8× 299 1.3× 203 0.9× 135 2.4k
Eleonora Turrini Italy 24 815 0.8× 191 0.5× 260 1.0× 202 0.9× 211 1.0× 62 2.0k
Amareshwar T.K. Singh United States 17 1.2k 1.3× 208 0.5× 458 1.7× 368 1.6× 150 0.7× 32 2.3k
David Y. Léger France 25 748 0.8× 170 0.4× 189 0.7× 134 0.6× 316 1.5× 57 1.8k
Renshuai Zhang China 23 1.0k 1.0× 283 0.7× 190 0.7× 189 0.8× 313 1.5× 84 1.9k
Paul Fitzpatrick United States 31 1.9k 2.0× 265 0.6× 333 1.3× 245 1.0× 205 1.0× 65 3.1k
Santosh Kumar Guru India 34 1.3k 1.3× 849 2.0× 340 1.3× 197 0.8× 249 1.2× 120 2.9k

Countries citing papers authored by Mehdi Rajabi

Since Specialization
Citations

This map shows the geographic impact of Mehdi Rajabi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mehdi Rajabi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mehdi Rajabi more than expected).

Fields of papers citing papers by Mehdi Rajabi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mehdi Rajabi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mehdi Rajabi. The network helps show where Mehdi Rajabi may publish in the future.

Co-authorship network of co-authors of Mehdi Rajabi

This figure shows the co-authorship network connecting the top 25 collaborators of Mehdi Rajabi. A scholar is included among the top collaborators of Mehdi Rajabi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mehdi Rajabi. Mehdi Rajabi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Glinsky, Gennadi V., Kavitha Godugu, Thangirala Sudha, et al.. (2022). Effects of Anticancer Agent P-bi-TAT on Gene Expression Link the Integrin Thyroid Hormone Receptor to Expression of Stemness and Energy Metabolism Genes in Cancer Cells. Metabolites. 12(4). 325–325. 4 indexed citations
2.
Godugu, Kavitha, et al.. (2020). Dual Targeting of Norepinephrine Transporter (NET) Function and Thyrointegrin αvβ3 Receptors in the Treatment of Neuroblastoma. Journal of Medicinal Chemistry. 63(14). 7653–7662. 14 indexed citations
3.
Rbaa, Mohamed, Parul Dohare, El Hassane Anouar, et al.. (2020). Synthesis, Characterization, Biocomputational Modeling and Antibacterial Study of Novel Pyran Based on 8-Hydroxyquinoline. Arabian Journal for Science and Engineering. 46(6). 5533–5542. 17 indexed citations
4.
Boukhatem, Mohamed Nadjib, et al.. (2020). A New Eucalyptol-Rich Lavender (Lavandula stoechas L.) Essential Oil: Emerging Potential for Therapy against Inflammation and Cancer. Molecules. 25(16). 3671–3671. 55 indexed citations
7.
Rajabi, Mehdi, Kavitha Godugu, Thangirala Sudha, Dhruba J. Bharali, & Shaker A. Mousa. (2019). Triazole Modified Tetraiodothyroacetic Acid Conjugated to Polyethylene Glycol: High Affinity Thyrointegrin αvβ3 Antagonist with Potent Anticancer Activities in Glioblastoma Multiforme. Bioconjugate Chemistry. 30(12). 3087–3097. 23 indexed citations
8.
Rajabi, Mehdi, et al.. (2019). Evaluation of Angiogenesis Assays. Biomedicines. 7(2). 37–37. 75 indexed citations
9.
Shu, Yi, Hongran Yin, Mehdi Rajabi, et al.. (2018). RNA-based micelles: A novel platform for paclitaxel loading and delivery. Journal of Controlled Release. 276. 17–29. 49 indexed citations
10.
Rajabi, Mehdi & Shaker A. Mousa. (2017). The Role of Angiogenesis in Cancer Treatment. Biomedicines. 5(2). 34–34. 502 indexed citations breakdown →
11.
Srinivasan, Mathangi, Mehdi Rajabi, & Shaker A. Mousa. (2015). Multifunctional Nanomaterials and Their Applications in Drug Delivery and Cancer Therapy. Nanomaterials. 5(4). 1690–1703. 109 indexed citations
12.
Shu, Yi, Fengmei Pi, Ashwani Sharma, et al.. (2013). Stable RNA nanoparticles as potential new generation drugs for cancer therapy. Advanced Drug Delivery Reviews. 66. 74–89. 204 indexed citations
13.
Rajabi, Mehdi, et al.. (2011). Naphthalene-Fused (α-Alkoxycarbonyl)Methylene-γ-Butyrolactones: Antiproliferative Activity and Binding to Bovine Serum Albumin and DNA. DNA and Cell Biology. 31(5). 783–789. 15 indexed citations
14.
15.
Rajabi, Mehdi, Mohammad A. Khalilzadeh, & Jamshid Mehrzad. (2011). Antiproliferative Activity of Novel Derivative of Thiopyran on Breast and Colon Cancer Lines and DNA Binding. DNA and Cell Biology. 31(1). 128–134. 15 indexed citations
16.
Rajabi, Mehdi, Filippo Minutolo, Simone Bertini, Marco Macchia, & Riccardo Ghidoni. (2011). Antiproliferative Activity and Cell Cycle Analysis of 2-(3,5-Dihydroxyphenyl)-6-Hydroxybenzothiazole on MCF-7 Breast and HCT-15 Colon Cancer Cell Lines. DNA and Cell Biology. 30(8). 617–621. 3 indexed citations
17.
Mehrzad, Jamshid & Mehdi Rajabi. (2011). Kinetin (N 6 -furfuryladenine): Cytotoxicity against MCF-7 breast cancer cell line and interaction with bovine serum albumin. AFRICAN JOURNAL OF BIOTECHNOLOGY. 10(33). 6304–6309. 6 indexed citations
18.
Rajabi, Mehdi, et al.. (2011). Antiproliferative Activity of N 6 -Isopentenyladenosine on HCT-15 Colon Carcinoma Cell Line. Nucleic Acid Therapeutics. 21(5). 355–358. 6 indexed citations
19.
Rajabi, Mehdi, et al.. (2010). Antiproliferative Activity of N 6 -Isopentenyladenosine on MCF-7 Breast Cancer Cells: Cell Cycle Analysis and DNA-Binding Study. DNA and Cell Biology. 29(11). 687–691. 25 indexed citations
20.
Nafisi, Shohreh, et al.. (2008). DNA Adducts with Antioxidant Flavonoids: Morin, Apigenin, and Naringin. DNA and Cell Biology. 27(8). 433–442. 85 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026